Literature DB >> 1719987

Quantitation of IgM- and IgG-secreting B cells in the peripheral blood of patients with systemic lupus erythematosus.

D M Klinman1, A Shirai, Y Ishigatsubo, J Conover, A D Steinberg.   

Abstract

An enzyme-linked immunospot assay was used to quantitate the number of autoantibody-secreting B cells in the peripheral blood of 67 patients with systemic lupus erythematosus. These patients had 1.5-4-fold more lymphocytes secreting IgG and IgM per million peripheral blood lymphocytes than did normal controls. There was a concomitant increase in the number of B cells secreting antibodies reactive with a diverse panel of foreign and self antigens (including actin, myosin, tri-nitrophenylated keyhole limpet hemocyanin, ovalbumin, and retroviral gp160). By comparison, the number of B cells producing anti-DNA antibodies was increased disproportionately. The magnitude of this anti-DNA response correlated significantly with disease activity. Thus, B cell activation in human systemic lupus erythematosus had characteristics of both generalized (polyclonal) B cell activation and (auto)antigen-specific immune stimulation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1719987     DOI: 10.1002/art.1780341110

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  18 in total

1.  Receptor editing in peripheral B cell tolerance.

Authors:  Jeffrey S Rice; Jeffrey Newman; Chuansheng Wang; Daniel J Michael; Betty Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-19       Impact factor: 11.205

2.  Defining the role of mycophenolate mofetil in the treatment of proliferative lupus nephritis.

Authors:  Oliver Lenz; Alessia Fornoni; Gabriel Contreras
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  DNA vaccines: safety and efficacy issues.

Authors:  D M Klinman; M Takeno; M Ichino; M Gu; G Yamshchikov; G Mor; J Conover
Journal:  Springer Semin Immunopathol       Date:  1997

Review 4.  Genetic dissection of lupus nephritis in murine models of SLE.

Authors:  E K Wakeland; L Morel; C Mohan; M Yui
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

5.  Changes in immune cell frequencies after cyclophosphamide or mycophenolate mofetil treatments in patients with systemic lupus erythematosus.

Authors:  Ling Zhao; Zhenyu Jiang; Yanfang Jiang; Ning Ma; Kai Wang; Yandong Zhang
Journal:  Clin Rheumatol       Date:  2012-02-21       Impact factor: 2.980

6.  Pharmacodynamics of recombinant human DNase I in serum.

Authors:  W S Prince; D L Baker; A H Dodge; A E Ahmed; R W Chestnut; D V Sinicropi
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

Review 7.  Pathogenesis of systemic lupus erythematosus.

Authors:  C C Mok; C S Lau
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

8.  Flow cytometric analyses of the lymphocyte subsets in peripheral blood of children with untreated active juvenile dermatomyositis.

Authors:  M R O'Gorman; V Corrochano; J Roleck; M Donovan; L M Pachman
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

Review 9.  B cell depletion therapy in systemic lupus erythematosus.

Authors:  Jennifer Anolik; Iñaki Sanz; R John Looney
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

10.  Characterization of B-cell lines from SLE patients and their relatives.

Authors:  T Witte; K Hartung; F M Bode; R E Schmidt; H Deicher
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.